Genetic polymorphism in UDP-Glucuronosyltransferase 2B7 and colorectal cancer risk

Oncology Research

Volumn 17, Issue 7, 2009, Pages 323-329

  Van Der Logt, E M J ^a   Te Morsche, R H M ^a   Groenendaal, N ^a   Roelofs, H M J ^a   De Metz, M ^b   Van Der Stappen, J W ^b   Nagengast, F M ^a   Peters, W H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Colorectal cancer; Genetic polymorphism; UDP glucuronosyltransferase 2B7

Indexed keywords

DNA; GLUCURONOSYLTRANSFERASE; UDP GLUCURONOSYLTRANSFERASE, UGT2B7; UDP-GLUCURONOSYLTRANSFERASE, UGT2B7;

ARTICLE; CANCER STAGING; CASE CONTROL STUDY; COLORECTAL TUMOR; COMPARATIVE STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; POLYMERASE CHAIN REACTION; RISK FACTOR;

CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA; FEMALE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 65649144285     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504009787721203     Document Type: Article

References (46)

1. Bray, F.; Sankila, R.; Ferlay, J.; Parkin, D. M. Estimates of cancer incidence and mortality in Europe in 1995. Eur. J. Cancer 38:99-166; 2002.
2. Houlston, R. S.; Peto, J. Genetics of common cancers. In: Eeles, R. A.; Ponder, B.; Easton, D. E.; Horwich, A., eds. Inherited predisposition to cancer. London: Chapman Hall Medical; 1996:208-226.
3. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington, DC: World Cancer Research Fund/American Institute for Cancer Research; 2007:280-288.
4. Ames, B. N. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 221:1256-1264; 1983.
5. Wakai, K.; Hirose, K.; Matsuo, K.; Ito, H.; Kuriki, K.; Suzuki, T.; Kato, T.; Hirai, T.; Kanemitsu, Y.; Tajima, K. Dietary risk factors for colon and rectal cancers: A comparative case-control study. J. Epidemiol. 16:125-135; 2006. (Pubitemid 43796773)
6. Potter, J. D. Colorectal cancer: Molecules and population. J. Natl. Cancer Inst. 91:916-932; 1999.
7. Butler, L. M.; Sinha, R.; Millikan, R. C.; Martin, C. F.; Newman, B.; Gammon, M. D.; Ammerman, A. S.; Sandler, R. S. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. Am. J. Epidemiol. 157:434-445; 2003.
8. de Waziers, I.; Cugnenc, P. H.; Yang, C. S.; Leroux, J. P.; Beaune, P. H. Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J. Pharmacol. Exp. Ther. 253:387-394; 1990.
9. Williams, R. T. Detoxification mechanisms, 2nd ed. New York: Wiley and Sons; 1971.
10. Tukey, R. H.; Strassburg, C. P. Human UDP-glucuronosyltransferases: Metabolism, expression, and disease. Annu. Rev. Pharmacol. Toxicol. 40:581-616; 2000.
11. Tukey, R. H.; Strassburg, C. P. Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract. Mol. Pharmacol. 59:405-414; 2001.
12. Mackenzie, P. I.; Owens, I. S.; Burchell, B.; Bock, K. W.; Bairoch, A.; Belanger, A.; Fournel-Gigleux, S.; Green, M.; Hum, D. W.; Iyanagi, T.; Lancet, D.; Louisot, P.; Magdalou, J.; Chowdhury, J. R.; Ritter, J. K.; Schachter, H.; Tephly, T. R.; Tipton, K. F.; Nebert, D. W. The UDP glycosyltransferase gene superfamily: Recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7:255-269; 1997.
13. Peters, W. H. M.; Kock, L.; Nagengast, F. M.; Kremers, P. G. Biotransformation enzymes in human intestine: Critical low levels in the colon? Gut 32:408-412; 1991.
14. Peters, W. H. M.; Roelofs, H. M. J.; Hectors, M. P.; Nagengast, F. M.; Jansen, J. B. M. J. Glutathione and glutathione S-transferases in Barrett's epithelium. Br. J. Cancer 67:1413-1417; 1993.
15. Peters, W. H. M.; Nagengast, F. M.; van Tongeren, J. H. M. Glutathione S-transferase, cytochrome P450, and uridine-5′-diphosphate- glucuronosyltransferase in human small intestine and liver. Gastroenterology 96:783-789; 1989.
16. Basu, N. K.; Ciotti, M.; Hwang, M. S.; Kole, L.; Mitra, P. S.; Cho, J. W.; Owens, I. S. Differential and special properties of the major human UGT1-encoded gastrointestinal UDP-glucuronosyltransferases enhance potential to control chemical uptake. J. Biol. Chem. 279:1429-1441; 2004.
17. Miners, J. O.; McKinnon, R. A.; Mackenzie, P. I. Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology 181-182:453-456; 2002.
18. Sachse, C.; Smith, G.; Wilkie, M. J.; Barrett, J. H.; Waxman, R.; Sullivan, F.; Forman, D.; Bishop, D. T.; Wolf, C. R. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23:1839-1849; 2002.
19. de Jong, M. M.; Nolte, I. M.; te Meerman, G. J.; van der Graaf, W. T. A.; de Vries, E. G. E.; Sijmons, R. H.; Hofstra, R. M. W.; Kleibeuker, J. H. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer. Epidemiol. Biomarkers Prev. 11:1332-1352; 2002.
20. Houlston, R. S.; Tomlinson, I. P. Polymorphisms and colorectal tumor risk. Gastroenterology 121:282-301; 2001.
21. Strassburg, C. P.; Vogel, A.; Kneip, S.; Tukey, R. H.; Manns, M. P. Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer. Gut 50:851-856; 2001.
22. van der Logt, E. M. J.; Bergevoet, S. M.; Roelofs, H. M. J.; te Morsche, R. H. M.; van Dijk, Y.; Wobbes, T.; Nagengast, F. M.; Peters, W. H. M. Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat. Res. 593:39-49; 2006.
23. van der Logt, E. M. J.; Bergevoet, S. M.; Roelofs, H. M. J.; van Hooijdonk, Z.; te Morsche, R. H. M.; Wobbes, T.; de Kok, J. B.; Nagengast, F. M.; Peters, W. H. M. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 25:2407-2415; 2004.
24. Radominska-Pandya, A.; Little, J. M.; Pandya, J. T.; Tephly, T. R.; King, C. D.; Barone, G. W.; Raufman, J. P. UDP-glucuronosyltransferases in human intestinal mucosa. Biochim. Biophys. Acta 1394:199-208; 1998.
25. Czernik, P. J.; Little, J. M.; Barone, G. W.; Raufman, J. P.; Radominska-Pandya, A. Glucuronidation of estrogens and retinoic acid and expression of UDP-glucuronosyltransferase 2B7 in human intestinal mucosa. Drug Metab. Dispos. 28:1210-1216; 2000.
26. Radominska-Pandya, A.; Little, J. M.; Czernik, P. Human UDP-glucuronosyltransferase 2B7. Curr. Drug Metab. 2:283-298; 2001.
27. Gestl, S. A.; Green, M. D.; Shearer, D. A.; Frauenhoffer, E.; Tephly, T. R.; Weisz, J. Expression of UGT2B7, UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers. Am. J. Pathol. 160:1467-1479; 2002.
28. Ren, Q.; Murphy, S. E.; Zheng, Z.; Lazarus, P. O-Glucuronidation of the lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by human UDP-glucuronosyltransferases 2B7 and 1A9. Drug Metab. Dispos. 28:1352-1360; 2000.
29. Kuehl, G. E.; Lampe, J. W.; Potter, J. D.; Bigler, J. Glucuronidation of nonsteroidal anti-inflammatory drugs: Identifying the enzymes responsible in human liver microsomes. Drug Metab. Dispos. 33:1027-1035; 2005.
30. Jin, C.; Miners, J. O.; Lillywhite, K. J.; Mackenzie, P. Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J. Pharmacol. Exp. Ther. 264:475-479; 1993.
31. Mackenzie, P.; Little, J. M.; Radominska-Pandya, A. Glucosidation of hyodeoxycholic acid by UDP-glucuronosyltransferase 2B7. Biochem. Pharmacol. 65:417-421; 2003.
32. Bhasker, C. R.; McKinnon, W.; Stone, A.; Lo, A. C.; Kubota, T.; Ishizaki, T.; Miners, J. O. Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: Ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 10:679-685; 2000.
33. Lin, G. F.; Guo, W. C.; Chen, J. G.; Qin, Y. Q.; Golka, K.; Xiang, C. Q.; Ma, Q. W.; Lu, D. R.; Shen, J. H. An association of UDP-glucuronosyltransferase 2B7 C802T (His268 Tyr) polymorphism with bladder cancer in benzidine-exposed workers in China. Toxicol. Sci. 85:502-506; 2005.
34. Lampe, J. W.; Bigler, J.; Bush, A. C.; Potter, J. D. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol. Biomarkers Prev. 9:329-333; 2000.
35. Swanson, C.; Lorentzon, M.; Vandenput, L.; Labrie, F.; Rane, A.; Jakobsson, J.; Chouinard, S.; Bélanger, A.; Ohlsson, C. Sex steroid levels and cortical bone size in young men are associated with a uridine diphosphate glucuronosyltransferase 2B7 polymorphism (H268Y). J. Clin. Endocrinol. Metab. 92:3697-3704; 2007.
36. Sawyer, M. B.; Innocenti, F.; Das, S.; Cheng, C.; Ramírez, J.; Pantle-Fisher, F. H.; Wright, C.; Badner, J.; Pei, D.; Boyett, J. M.; Cook, Jr., E.; Ratain, M. J. A pharmacogenetic study of uridine diphosphate- glucuronosyltransferase 2B7 in patients receiving morphine. Clin. Pharmacol. Ther. 73:566-574; 2003.
37. Alberts, D. S.; Martínez, M. E.; Hess, L. M.; Einspahr, J. G.; Green, S. B.; Bhattacharyya, A. K.; Guillen, J.; Krutzsch, M.; Batta, A. K.; Salen, G.; Fales, L.; Koonce, K.; Parish, D.; Clouser, M.; Roe, D.; Lance, P.; Phoenix and Tucson Gastroenterologist Networks. Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J. Natl. Cancer Inst. 97:846-853; 2005.
38. Ito, Y.; Suzuki, K.; Ishii, J.; Hishida, H.; Tamakoshi, A.; Hamajima, N.; Aoki, K. A population-based follow-up study on mortality from cancer or cardiovascular disease and serum carotenoids, retinol and tocopherols in Japanese inhabitants. Asian Pac. J. Cancer Prev. 7:533-546; 2006.
39. Nazeri, K.; Khatibi, A.; Nyberg, P.; Agardh, C. D.; Lidfeldt, J.; Samsioe, G. Colorectal cancer in middle-aged women in relation to hormonal status: A report from the Women's Health in the Lund Area (WHILA) study. Gynecol. Endocrinol. 22:416-422; 2006.
40. Guillemette, C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J. 3: 136-158; 2003.
41. Thibaudeau, J.; Lépine, J.; Tojcic, J.; Duguay, Y.; Pelletier, G.; Plante, M.; Brisson, J.; Têtu, B.; Jacob, S.; Perusse, L.; Bélanger, A.; Guillemette, C. Characterization of common UGT1A8, UGT1A9, and UGT2B7 variants with different capacities to inactivate mutagenic 4-hydroxylated metabolites of estradiol and estrone. Cancer Res. 66:125-133; 2006.
42. Wiener, D.; Fang, J. L.; Dossett, N.; Lazarus, P. Correlation between UDP-glucuronosyltransferase genotypes and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone glucuronidation phenotype in human liver microsomes. Cancer Res. 64:1190-1196; 2004. (Pubitemid 38176928)
43. Vandenput, L.; Mellström, D.; Lorentzon, M.; Swanson, C.; Karlsson, M. K.; Brandberg, J.; Lönn, L.; Orwoll, E.; Smith, U.; Labrie, F.; Ljunggren, O.; Tivesten, A.; Ohlsson, C. Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. J. Clin. Endocrinol. Metab. 92:4130-4137; 2007.
44. McGreavey, L. E.; Turner, F.; Smith, G.; Boylan, K.; Timothy Bishop, D.; Forman, D.; Roland Wolf, C.; Barrett, J. H.; Colorectal Cancer Study Group. No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma. Pharmacogenet. Genomics 15:713-721; 2005.
45. Bigler, J.; Whitton, J.; Lampe, J. W.; Fosdick, L.; Bostick, R. M.; Potter, J. D. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res. 61:3566-3569; 2001.
46. te Morsche, R. H. M.; Drenth, J. P. H.; Truninger, K.; Schulz, H. U.; Kage, A.; Landt, O.; Verlaan, M.; Rosendahl, J.; Macek, Jr., M.; Jansen, J. B. M. J.; Witt, H. UGT1A7 polymorphisms in chronic pancreatitis: An example of genotyping pitfalls. Pharmacogenomics J. 8:34-41; 2008.